Publications
- New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting2008 | First Faculty of Medicine
- Overcoming Immunoescape Mechanisms of BCL1 Leukemia and Induction of CD8(+) T-Cell-Mediated BCL1-Specific Resistance in Mice Cured by Targeted Polymer-Bound Doxorubicin2008 | First Faculty of Medicine
- Immunologic functions in tumor-bearing mice treated with doxorubicin and HPMA-bound doxorubicin (PK1)2000 | First Faculty of Medicine
- Establishment of systemic anti-cancer immunity in mice after the treatment with polymer-bound doxorubicinPublication without faculty affiliation
- First clinical experience with HMPA copolymer-bound doxorubicin in patients with advanced breast cancerPublication without faculty affiliation
- Cytotoxic and immunostimulating activities of polymer-bound drugsPublication without faculty affiliation
- Antibody-targeted HPMA copolymer-bound doxorubicin conjugates can completely cure tumor-bearing mice and establish long-term immunological memory against the original tumorPublication without faculty affiliation
- Palliative therapy of advanced breast cancer with targeted polymer-bound drugPublication without faculty affiliation
- Cytotoxic and immunomodulatory activities of polymer-bound drugsPublication without faculty affiliation
- Targeted polymer-bound drugs for cancer therapyPublication without faculty affiliation
Loading network view...